Regeneron Pharmaceuticals (REGN)
(Delayed Data from NSDQ)
$883.20 USD
-7.48 (-0.84%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $881.43 -1.77 (-0.20%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth A Momentum C VGM
Earnings News For REGN
-
Regeneron (REGN) Reports Next Week: What You Should Expect
-
Regeneron (REGN) Gets FDA Nod for Praluent Label Extension
-
Regeneron (REGN) Q4 Earnings & Sales Top, Eylea Sales Decline
-
Regeneron: Q4 Earnings Snapshot
-
Regeneron (REGN) Q4 Earnings and Revenues Top Estimates
-
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
-
Regeneron (REGN) to Report Q4 Earnings: What's in the Cards?
-
Earnings Preview: Regeneron (REGN) Q4 Earnings Expected to Decline
-
Regeneron (REGN) Q3 Earnings & Sales Top, Eylea Sales Decline
-
Regeneron: Q3 Earnings Snapshot
-
Regeneron Reports Third Quarter 2023 Financial and Operating Results
-
Regeneron (REGN) to Report Q3 Earnings: What's in the Cards?
-
Analysts Estimate Regeneron (REGN) to Report a Decline in Earnings: What to Look Out for
-
Regeneron (REGN) Q2 Earnings & Sales Top, Eylea Sales Decline
-
Regeneron (REGN) Tops Q2 Earnings and Revenue Estimates
-
Regeneron Reports Second Quarter 2023 Financial and Operating Results
-
Regeneron (REGN) to Report Q2 Earnings: What's in Store?
-
Regeneron (REGN) Q1 Earnings & Sales Top, Eylea Sales Decline
-
Regeneron (REGN) Q1 Earnings and Revenues Top Estimates
-
Regeneron: Q1 Earnings Snapshot
-
Regeneron Reports First Quarter 2023 Financial and Operating Results
-
Is a Beat on the Cards for Regeneron's (REGN) Q1 Earnings?
-
Regeneron (REGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Regeneron (REGN) Q4 Earnings & Sales Beat, Eylea Sales Decline
-
Regeneron: Q4 Earnings Snapshot